Sanofi-aventis' fourth-quarter and full-year net sales
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](/images/stories/logo/sanofi-aventis.gif)
Novartis drug Afinitor® extends progression-free survival in patients with advanced pancreatic NET
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
FDA Grants Orphan Drug Designation to Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Third phase III study of Avastin-based regimen met primary endpoint in ovarian cancer
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
GSK revises US Avandia label to include new restrictions on use
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
Pfizer To Acquire Ferrosan's Consumer Healthcare Business
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Nycomed to acquire Colombian company Farmacol
- Details
- Category: Nycomed
![Nycomed Nycomed](/images/stories/logo/nycomed.gif)
More Pharma News ...
- New Co-Promotion Agreements For Rheumatoid Arthritis Products In Japan
- GSK's full year trading update
- The Roche Group posted solid overall results in 2010
- Novo Nordisk increased operating profit by 27% in 2010
- Pfizer Reports Fourth-Quarter and Full-Year 2010 Results
- Pfizer Completes Tender Offer For Shares Of King Pharmaceuticals, Inc.
- Genzyme Will Allow sanofi-aventis to Conduct Due Diligence